Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma

MLA

Tsukasa Narukawa, et al. “Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma.” Case Reports in Oncology, vol. 13, no. 1, Mar. 2020, pp. 249–54. EBSCOhost, https://doi.org/10.1159/000506196.

APA

Tsukasa Narukawa, Fumiya Hongo, Atsuko Fujihara, Akihisa Ueno, Toru Matsugasumi, & Osamu Ukimura. (2020). Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma. Case Reports in Oncology, 13(1), 249–254. https://doi.org/10.1159/000506196

Chicago

Tsukasa Narukawa, Fumiya Hongo, Atsuko Fujihara, Akihisa Ueno, Toru Matsugasumi, and Osamu Ukimura. 2020. “Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma.” Case Reports in Oncology 13 (1): 249–54. doi:10.1159/000506196.